Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Debt / DBCV 0.250% 2/0
-
Market price (% of par)
-
93.05%
-
Total 13F principal
-
$395,159,955
-
Principal change
-
-$14,301,828
-
Total reported market value
-
$371,374,363
-
Number of holders
-
52
-
Value change
-
-$14,265,489
-
Number of buys
-
15
-
Number of sells
-
20
Institutional Holders of TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 as of Q1 2020
As of 31 Mar 2020,
TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 was held by
52 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$395,159,955
in principal (par value) of the bond.
The largest 10 bondholders included
Allianz Asset Management GmbH, LMR Partners LLP, Western Asset Management Company, LLC, WESTWOOD HOLDINGS GROUP INC, WELLS FARGO & COMPANY/MN, Polar Capital LLP, AMUNDI PIONEER ASSET MANAGEMENT INC, SYMPHONY ASSET MANAGEMENT LLC, ONTARIO TEACHERS PENSION PLAN BOARD, and Radcliffe Capital Management, L.P..
This page lists
52
institutional bondholders reporting positions
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.